The earlier you find, the better you treat: red flags for early diagnosis of inflammatory bowel disease
L Cantoro, R Monterubbianesi, G Falasco, C Camastra… - Diagnostics, 2023 - mdpi.com
Delayed diagnosis is a challenge in the management of inflammatory bowel disease (IBD).
Several studies show a significant association between diagnostic delay and disease …
Several studies show a significant association between diagnostic delay and disease …
[HTML][HTML] Diagnosis and natural history of preclinical and early inflammatory bowel disease
I Rodríguez-Lago, Y Zabana… - Annals of …, 2020 - ncbi.nlm.nih.gov
Inflammatory bowel disease is a chronic and progressive disorder of the gastrointestinal
tract. A relevant proportion of patients develop complicated lesions, defined as strictures …
tract. A relevant proportion of patients develop complicated lesions, defined as strictures …
Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn's disease
I Rodríguez-Lago, JD Hoyo… - United European …, 2020 - journals.sagepub.com
Background There is limited evidence on the effectiveness of biological therapy in stricturing
complications in patients with Crohn's disease. Aim The study aims to determine the …
complications in patients with Crohn's disease. Aim The study aims to determine the …
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn's disease: a real-world multicenter …
RS Parra, JMF Chebli, NSF Queiroz… - BMC …, 2022 - Springer
Background The effectiveness of ustekinumab (UST) in the treatment of Crohn's disease
(CD) has been demonstrated in the pivotal Phase 3 UNITI 1 and 2 and IM-UNITI studies in …
(CD) has been demonstrated in the pivotal Phase 3 UNITI 1 and 2 and IM-UNITI studies in …
Hematopoietic stem cell transplantation and Crohn's disease: position paper from the Transplantation Committee of the Brazilian Group for the Study of Inflammatory …
Crohn's disease (CD) is a relapse-remitting inflammatory bowel disease that can affect any
part of the digestive system. This heterogeneous disease has multiple factors that contribute …
part of the digestive system. This heterogeneous disease has multiple factors that contribute …
Bowel Damage and Disability in Crohn's Disease: Is it Really Two Birds with One Stone?
T Innocenti, G Dragoni - Inflammatory Bowel Diseases, 2024 - academic.oup.com
In 1976, the World Health Organization (WHO) defined disability as “any restriction or lack
(resulting from an impairment) of ability to perform an activity in the manner or within the …
(resulting from an impairment) of ability to perform an activity in the manner or within the …
[HTML][HTML] Predictors of bowel damage in the long-term progression of Crohn's disease
A Fernández-Clotet, J Panés, E Ricart… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Crohn's disease (CD) is a chronic inflammatory bowel disorder that
progresses to bowel damage (BD) over time. An image-based index, the Lémann index (LI) …
progresses to bowel damage (BD) over time. An image-based index, the Lémann index (LI) …
Machine learning for selecting patients with Crohn's disease for abdominopelvic computed tomography in the emergency department
T Konikoff, I Goren, M Yalon, S Tamir… - Digestive and Liver …, 2021 - Elsevier
Abstract Background Patients with Crohn's disease (CD) frequently undergo
abdominopelvic computed tomography (APCT) in the emergency department (ED). It's …
abdominopelvic computed tomography (APCT) in the emergency department (ED). It's …
Discriminant equation using mucosally expressed cytokines and transcription factor for making definite diagnosis of inflammatory bowel disease unclassified
H Okuno, H Ogino, E Ihara, K Nishioka, Y Tanaka… - BMC …, 2021 - Springer
Background The pathological conditions of UC and CD involved in inflammatory bowel
disease-unclassified (IBD-U), UC with primary sclerosing cholangitis (PSC-UC), and UC …
disease-unclassified (IBD-U), UC with primary sclerosing cholangitis (PSC-UC), and UC …
Identifying for some Immune and Hematological Indicators in Crohn, s Patients Infested through Entamoeba histolytica Infection
RA Sayal, F Hashim - 2024 - researchsquare.com
Objective: The current study aimed to diagnose the Entamoeba histolytica parasite in crohn,
s disease patients. addition to measure immunological indicators (interleukin-34 and …
s disease patients. addition to measure immunological indicators (interleukin-34 and …